Latest Financials News

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Burgundy Diamond Mines has responded to ASX scrutiny over its related-party financing with Choron Holdings, asserting the arrangements were short-term, non-material cash-flow facilities properly disclosed in its half-year accounts.

Predictive Discovery and Robex Resources have completed all merger steps except the final administrative confirmation from Quebec, bringing the combined West African gold producer closer to operational integration.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.

Future Metals has unveiled a lower-risk, lower-capital pathway for its Panton PGM Project by leveraging the idle Savannah Plant, delivering upfront savings of around A$74 million and preserving long-term growth potential.

Beacon Minerals produced 5,419 ounces of gold in Q1 2026 amid operational shifts at Jaurdi, completed key asset sales to Forrestania, and set a June quarter production target of 5,000 to 6,000 ounces.

Solstice Minerals has reported standout Phase 1 drilling at its Nanadie Copper-Gold Project, highlighting wide, high-grade intercepts that surpass current resource grades. Supported by a $32.6 million placement, the company is accelerating Phase 2 drilling to expand this promising WA copper-gold system.

Livium has extended its recycling agreement with Sell & Parker by a year, secured an upfront deposit, and is ramping up processing volumes with a new dedicated plant at Campbellfield.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.

Midas Minerals has raised $28 million through a heavily supported placement to fund expanded drilling and feasibility studies at its Otavi project in Namibia. The capital boost lifts the company’s cash reserves to approximately $33 million, underpinning an aggressive exploration push.

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.